Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 49
Filtrar
2.
Pediatr Dermatol ; 41(1): 184-186, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38284783

RESUMEN

"Corymbiform" is a term found in medical literature as early as 1876 to describe a central larger lesion with smaller surrounding lesions, leading to the appearance of an irregular border. While the term in current medical literature most often describes a possible morphology of secondary syphilis, the authors have noted this pattern presenting in other cutaneous conditions. We present a commentary on the corymbiform pattern in dermatology including a series of photographs of cutaneous disorders presenting in a corymbiform morphology in pediatric patients. While the term corymbiform is not commonly used in the present-day dermatologic literature, increased recognition and use of this term may aid in the recognition of various dermatologic diagnoses presenting in a less common morphology and may also lend to increased fluidity of dermatologic descriptions in the literature.


Asunto(s)
Dermatitis , Dermatología , Lupus Eritematoso Cutáneo , Sífilis , Humanos , Niño , Sífilis/diagnóstico
3.
Clin Med Insights Pediatr ; 17: 11795565231194819, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37654602

RESUMEN

Molluscum contagiosum (MC) is a viral cutaneous infection common in children. It is characterized by umbilicated, skin-colored papules that typically resolve without treatment over several months to years. Immune response to the virus may cause inflammatory reactions, including molluscum dermatitis, inflamed molluscum, Gianotti-Crosti syndrome-like reaction, erythema annulare centrifugum, or even a generalized id reaction (a reactive inflammatory process driven by a separate condition that stimulates the immune system). We report a unique case of a granuloma annulare-like id reaction secondary to immune recognition of MC in a pediatric patient followed by rapid resolution of their MC.

5.
Pediatr Dermatol ; 37(1): 142-146, 2020 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-31854003

RESUMEN

BACKGROUND/OBJECTIVES: Atopic dermatitis (AD) is the most common skin disease of childhood and is often more severe in African American than white children. The reason for this disparity is unknown, but recent research indicates that it may be due to a combination of environmental and genetic factors. The objective of this article was to explore the relationship between measures of structural racism and residential segregation within pediatric AD. METHODS: An in-office, online survey consisting of 58 questions spanning 5 domains (demographics, in-home crowding, community crowding, air quality, and litter) was administered to a convenience sample of 201 pediatric AD patients (age 0-18 years). Survey data were geocoded and linked to a measure of structural racism (ie, residential segregation). RESULTS: African American children were more likely to live in rented homes, be in lower income families, have caregivers with lower educational attainment, and be exposed to tobacco smoke. The same factors that were associated with worse AD severity in this study were also found in published literature, emphasizing the role of social determinants of health and racial differences in AD severity. Additionally, this study found that living in highly segregated communities was more likely to be associated with severe AD in African American children. CONCLUSIONS: Consistent with reported literature, socioeconomic status, race, and the physical environment appear to affect AD severity. This investigation adds structural racism as an important community characteristic that likely has significant effects on AD severity for African American Children.


Asunto(s)
Negro o Afroamericano , Dermatitis Atópica/etnología , Racismo , Contaminación del Aire , Niño , Aglomeración , Demografía , Femenino , Residuos de Alimentos , Humanos , Masculino , Factores de Riesgo , Índice de Severidad de la Enfermedad , Encuestas y Cuestionarios
10.
Pediatr Dermatol ; 34(3): e150-e151, 2017 May.
Artículo en Inglés | MEDLINE | ID: mdl-28523896

RESUMEN

Hemophagocytic lymphohistiocytosis (HLH) is a rare, life-threatening hyperinflammatory syndrome characterized by uncontrolled activation and proliferation of proinflammatory cytokines. Initial presentation commonly includes fever, hepatosplenomegaly, and pancytopenia; 6 to 65% of cases also have a concurrent cutaneous eruption. We present the case of a 6-day-old premature infant boy with congenital severe thrombocytopenia, anemia, and hepatosplenomegaly who presented with several cutaneous violaceous papules and nodules and was found to have HLH.


Asunto(s)
Exantema/patología , Recien Nacido Prematuro , Linfohistiocitosis Hemofagocítica/patología , Anemia/diagnóstico , Anemia/etiología , Biopsia con Aguja , Diagnóstico Diferencial , Exantema/diagnóstico , Estudios de Seguimiento , Humanos , Inmunohistoquímica , Recién Nacido , Linfohistiocitosis Hemofagocítica/diagnóstico , Masculino , Pancitopenia/diagnóstico , Pancitopenia/etiología , Medición de Riesgo , Índice de Severidad de la Enfermedad , Enfermedades Cutáneas Vesiculoampollosas , Esplenomegalia/diagnóstico , Esplenomegalia/etiología
11.
FP Essent ; 453: 18-25, 2017 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-28196317

RESUMEN

Cutaneous adverse drug reactions are among the most common noninfectious rashes of childhood. Cutaneous adverse drug reactions are classified as morbilliform, urticarial, bullous, pustular, or psoriasiform. Atopic dermatitis is one of the most common inflammatory cutaneous eruptions, and is characterized by pruritus and flexural distribution. Emollients and topical corticosteroids are first-line therapies. Topical calcineurin inhibitors are second-line, steroid-sparing drugs for certain conditions, such as face and eyelid eczema. Systemic and immunologic conditions have mucocutaneous features, such as malar rash, discoid lupus, and photosensitivity in systemic lupus erythematosus; lip, oral, and extremity changes as well as polymorphous rash in Kawasaki disease; erythematous, scaly plaques in psoriasis; and xerosis and face, hand, and leg skin changes in type 1 diabetes. Genetic conditions that manifest as changes in skin pigmentation are important to recognize because of the thorough diagnostic evaluation they warrant, the often challenging interventions they necessitate, and the permanent disability that frequently accompanies them. These conditions include neurofibromatosis, LEOPARD syndrome, incontinentia pigmenti, congenital hemidysplasia with ichthyosiform erythroderma and limb defects syndrome, hypomelanosis of Ito, and acanthosis nigricans. Childhood dermatologic emergencies often are associated with infection and drugs and require early recognition and intervention.


Asunto(s)
Fármacos Dermatológicos/uso terapéutico , Medicina Familiar y Comunitaria , Enfermedades de la Piel/fisiopatología , Enfermedades de la Piel/terapia , Corticoesteroides/uso terapéutico , Niño , Dermatitis/fisiopatología , Dermatitis/terapia , Diabetes Mellitus Tipo 1/fisiopatología , Diabetes Mellitus Tipo 1/terapia , Erupciones por Medicamentos/fisiopatología , Erupciones por Medicamentos/terapia , Eccema/fisiopatología , Eccema/terapia , Humanos , Lupus Eritematoso Sistémico/fisiopatología , Lupus Eritematoso Sistémico/terapia , Síndrome Mucocutáneo Linfonodular/fisiopatología , Síndrome Mucocutáneo Linfonodular/terapia , Prurito/fisiopatología , Prurito/terapia , Psoriasis/fisiopatología , Psoriasis/terapia , Enfermedades de la Piel/diagnóstico
12.
FP Essent ; 453: 33-37, 2017 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-28196319

RESUMEN

Congenital melanocytic nevi (CMN) are hamartomas present at birth that are composed of nevomelanocytes and thought to originate from faulty migration of precursor melanocytes in the neural crest. Classification is based on projected adult size of the lesion. CMN size correlates positively with risk of melanoma and neurocutaneous melanocytosis. Management requires a patient-centered approach that weighs the risks and benefits of and alternatives to complete removal. All children with large and giant CMN, regardless of surgical status, should be monitored closely and undergo periodic skin examination. Infantile hemangiomas (IHs) are vascular neoplasms arising from endothelial cell hyperplasia that go through proliferative (growth) and involutional phases. Large, segmental IHs carry a higher risk of bleeding, and patients with these IHs may benefit from imaging. Small, focal IHs in noncritical areas do not require treatment. In contrast, early referral and treatment should be considered for patients with large, extensive, deep, segmental, or syndromic IHs. Systemic and topical beta blockers have the strongest efficacy data and have replaced systemic and intralesional corticosteroids as first-line treatment for IHs in the United States. Surgical therapies are second-line modalities, with laser treatment being used most widely.


Asunto(s)
Medicina Familiar y Comunitaria , Hemangioma/congénito , Nevo Pigmentado/congénito , Neoplasias Cutáneas/congénito , Niño , Preescolar , Hemangioma/epidemiología , Hemangioma/terapia , Humanos , Lactante , Recién Nacido , Nevo Pigmentado/patología , Nevo Pigmentado/terapia , Neoplasias Cutáneas/patología , Neoplasias Cutáneas/terapia
13.
Pediatr Dermatol ; 33(2): e106-8, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27001331

RESUMEN

Hair follicle nevi are rare, benign, congenital hamartomas that usually occur in the distribution of the first brachial arch. Histopathologically, the distinction between hair follicle nevus, trichofolliculoma, and accessory tragus has recently come into question, and it may be that they are all on a spectrum of the same condition. We report the case of a 7-day-old boy who presented with a "tag"-like lesion on his midline chin that had been present since birth. Biopsy of the lesion proved it to be a hair follicle nevus.


Asunto(s)
Enfermedades del Cabello/patología , Folículo Piloso/patología , Nevo/patología , Neoplasias Cutáneas/patología , Mentón/patología , Diagnóstico Diferencial , Humanos , Lactante , Recién Nacido , Masculino
15.
JAMA Dermatol ; 149(5): 559-64, 2013 May.
Artículo en Inglés | MEDLINE | ID: mdl-23426075

RESUMEN

IMPORTANCE: The absence of data on the prevalence of pilomatricoma among patients with Turner syndrome served as the catalyst for this multicenter investigation. OBJECTIVES: To ascertain the prevalence of pilomatricoma among patients with Turner syndrome and to determine any association between the development of pilomatricomas and the use of exogenous hormones in patients with Turner syndrome. DESIGN: A retrospective medical record review from January 1, 2000, through January 1, 2010, was performed of all patients with Turner syndrome. Data on pilomatricomas and the use of hormone therapy were collected. SETTING: University of California-Davis Medical Center, University of Nebraska Medical Center, and The University of North Carolina at Chapel Hill. PARTICIPANTS: Patients with a diagnosis of Turner syndrome. MAIN OUTCOME MEASURES: Prevalence of concomitant pilomatricoma and diagnosis of Turner syndrome. Secondary outcome measures included the use of the exogenous hormones estrogen or recombinant human growth hormone (rhGH). RESULTS: In total, 311 patients with Turner syndrome were identified from these 3 institutions. Among them, 8 patients (2.6%) were diagnosed as having pilomatricomas. Before the development of pilomatricomas, 5 patients had been treated with rhGH but not estrogen, 1 patient had received estrogen but not rhGH, and 2 patients did not receive either therapy. CONCLUSIONS AND RELEVANCE: Although the prevalence of pilomatricoma among the general population is unknown, this study demonstrates a high prevalence (2.6%) of pilomatricomas among patients with Turner syndrome. No apparent relationship was noted among our patients or in the literature between the use of rhGH and the development of pilomatricomas.


Asunto(s)
Enfermedades del Cabello/epidemiología , Pilomatrixoma/epidemiología , Neoplasias Cutáneas/epidemiología , Síndrome de Turner/epidemiología , Adolescente , Niño , Preescolar , Estrógenos/efectos adversos , Femenino , Hormona de Crecimiento Humana/efectos adversos , Humanos , Prevalencia , Estudios Retrospectivos , Síndrome de Turner/tratamiento farmacológico , Adulto Joven
16.
Pediatr Dermatol ; 30(6): e110-3, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-22639953

RESUMEN

Koebner isomorphic response describes the phenomenon of histopathologically identical skin lesions of a preceding cutaneous disease appearing in sites of trauma. Wolf isotopic response describes the phenomenon of a new skin disease appearing in the site of an unrelated cutaneous disease. Neither of the phenomena has been reported in relation to systemic lupus erythematosus. This report describes a 17-year-old girl with systemic lupus erythematosus exhibiting particularly severe cutaneous involvement confined primarily to sun-exposed areas presenting with a dermatomal band of atrophic, scaling, erythematous papules, and plaques on her left shoulder extending down her left arm after herpes zoster eruption. The histopathologil result showed lupus erythematosus. This phenomenon is best considered as a Koebner isomorphic response, although Wolf isotopic response has some clinical relevance as well. Koebner isomorphic and Wolf isotopic responses are discussed as related to this case.


Asunto(s)
Herpes Zóster/complicaciones , Lupus Eritematoso Cutáneo/complicaciones , Lupus Eritematoso Cutáneo/virología , Lupus Eritematoso Sistémico/complicaciones , Adolescente , Biopsia , Femenino , Humanos , Lupus Eritematoso Cutáneo/patología , Índice de Severidad de la Enfermedad , Piel/patología , Luz Solar/efectos adversos
18.
Pediatr Dermatol ; 29(4): 498-503, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-21967522

RESUMEN

Anaplastic large cell lymphoma (ALCL) accounts for 10% to 30% of all childhood lymphomas and approximately 5% of all non-Hodgkin's lymphoma. ALCL is considered to be a T-cell non-Hodgkin's lymphoma that can be divided into two major groups with distinct genetic, immunophenotypic, and clinical behaviors. The first group consists of a spectrum of CD30+ T-cell lymphoproliferative disorders that include primary cutaneous ALCL (C-ALCL) and lymphomatoid papulosis. The second group is systemic ALCL (S-ALCL), which is further divided into two subgroups: anaplastic lymphoma kinase positive (ALK+) and ALK-negative. Between 30% and 60% of S-ALCL express ALK, which is usually the result of a t(2;5) translocation that correlates with onset in the first three decades of life, male predominance, and good prognosis. Although morphologically similar, ALK- ALCL shows varied clinical behaviors and immunophenotypes; is commonly seen in older age groups, with a peak incidence in the sixth decade of life with no preference as to sex; and has an overall poorer prognosis. We present a case of CD30+, ALK- S-ALCL in a 7-year-old girl.


Asunto(s)
Axila , Linfoma Anaplásico de Células Grandes/patología , Neoplasias Cutáneas/patología , Piel/patología , Biopsia , Niño , Femenino , Humanos
19.
Pediatr Dermatol ; 29(1): 49-52, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-21950618

RESUMEN

We have observed that some children with facial hemangiomas of infancy have feeding difficulties coincident with periods of failure to thrive. We evaluated the early oral sensory and feeding experiences of four children with facial hemangiomas through medical record review and parental surveys to investigate their contribution to the patients' failure to thrive. All children with feeding irregularities experienced some degree of oral sensory impairment and required early oral sensory intervention, but there were varying reports of difficulty or delay in the development of oral feeding. The nature of these difficulties is discussed. Infants with complicated facial hemangiomas with perioral and airway involvement may be at higher risk for feeding and oral sensory problems. We recommend close monitoring for failure to thrive and early evaluation by speech or occupational therapists.


Asunto(s)
Desarrollo Infantil , Discapacidades del Desarrollo/complicaciones , Insuficiencia de Crecimiento/complicaciones , Trastornos de Alimentación y de la Ingestión de Alimentos/complicaciones , Hemangioma/complicaciones , Discapacidades del Desarrollo/fisiopatología , Cara , Insuficiencia de Crecimiento/fisiopatología , Trastornos de Alimentación y de la Ingestión de Alimentos/fisiopatología , Femenino , Hemangioma/patología , Humanos , Lactante , Masculino
20.
Pediatr Dermatol ; 29(2): 169-76, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22066977

RESUMEN

Lupus erythematosus panniculitis (LEP) is a rare finding in children, with only 12 fully reported prior cases in the English literature. We describe three cases of LEP in children younger than 18 and compare them to previous cases reported in the literature. We examine laboratory tests performed, biopsy results, age at onset and diagnosis, presence or absence of systemic symptoms, and outcomes after treatment. It is unknown what the risk is of these patients developing future systemic lupus erythematosus. We also discuss the relevance of subcutaneous panniculitis-like T-cell lymphoma, because the clinical and pathologic pictures are similar in presentation.


Asunto(s)
Paniculitis de Lupus Eritematoso/diagnóstico , Paniculitis de Lupus Eritematoso/tratamiento farmacológico , Adolescente , Biopsia , Preescolar , Fármacos Dermatológicos/uso terapéutico , Quimioterapia Combinada , Femenino , Humanos , Hidroxicloroquina/uso terapéutico , Paniculitis de Lupus Eritematoso/patología , Prednisolona/uso terapéutico , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA